Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs High-dose PRP vs Saline for Glenohumeral Osteoarthritis
NCT05675527Phase 4Recruiting
- Sponsor
- Hospital for Special Surgery
- Start
- May 2023
- Primary completion
- Jun 2028
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised trial of platelet-rich plasma in shoulder osteoarthritis (3 arms), sponsored by Hospital for Special Surgery. Primary endpoint: American Shoulder and Elbow Surgeons Shoulder Score at 3 months. Started May 2023; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
shoulder osteoarthritis
Beyond the preview
Go deeper on NCT05675527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05675527.